Pityriasis isn’t a single disease. It’s a group of skin conditions that share a common feature: fine, flaky scaling on the skin’s surface. Each type has a different cause, ranging from viral reactivation to yeast overgrowth to genetic mutations. The most commonly searched form is pityriasis rosea, but understanding what triggers each type helps you identify what you’re dealing with and what to expect.
Pityriasis Rosea: A Viral Reactivation
Pityriasis rosea is the most common form, affecting roughly 0.5% to 2% of the population. It shows up as a large oval “herald patch” on the chest or back, followed days to weeks later by a spreading rash of smaller patches that fan out along the skin’s natural crease lines, often described as a “Christmas tree” pattern.
The leading cause is reactivation of human herpesviruses 6 and 7, the same viruses that cause roseola in young children. Nearly everyone carries these viruses from childhood. They remain dormant in the body for life, and something triggers them to become active again. In a study of 25 patients with pityriasis rosea, 40% had detectable viral DNA from herpesvirus 6 in their blood, and 16% showed herpesvirus 7 in skin tissue samples. Patients who tested positive for herpesvirus 7 DNA also had antibodies indicating active, recent infection rather than a distant past exposure. Importantly, none of the healthy control subjects had detectable virus, supporting the idea that reactivation plays a direct role.
What triggers this reactivation isn’t fully understood, but the condition follows a seasonal pattern that offers clues. In temperate climates, cases peak in winter. In tropical regions, they cluster during the monsoon and fall seasons. This seasonality, combined with the viral link, suggests that immune fluctuations tied to weather, stress, or other infections may allow the dormant virus to reawaken.
Medications Can Trigger It Too
Certain drugs can cause eruptions that look identical to pityriasis rosea. An analysis of the FDA’s adverse event database found that TNF inhibitors (a class of drugs used for autoimmune conditions like rheumatoid arthritis and Crohn’s disease) accounted for 19.2% of drug-associated pityriasis rosea cases. ACE inhibitors, commonly prescribed for high blood pressure, accounted for another 5%. Other medications linked to the rash include certain older antidepressants, blood pressure drugs like clonidine, and immunomodulating cancer therapies. The mechanisms behind these drug-triggered eruptions are largely unknown, but the rash typically resolves once the medication is stopped.
Pityriasis Versicolor: Yeast Already on Your Skin
Pityriasis versicolor (also called tinea versicolor) causes lighter or darker patches on the trunk and shoulders. Unlike pityriasis rosea, this one isn’t caused by a virus. It’s caused by Malassezia, a type of yeast that lives naturally on everyone’s skin. The three species most frequently involved are M. furfur, M. globosa, and M. sympodialis.
The yeast only becomes a problem when conditions shift in its favor. Normally it exists in a harmless round form, but certain triggers cause it to convert into a thread-like form that disrupts skin pigmentation. The biggest environmental trigger is heat and humidity, which is why the condition is far more common in tropical climates and flares during summer months. Other factors that tip the balance include excessive sweating, oily skin or the use of greasy moisturizers, pregnancy, oral contraceptives, corticosteroid use, and even wearing occlusive face masks for extended periods. Genetic predisposition also plays a role, which is why some people deal with recurring episodes while others living in the same environment never develop it.
Pityriasis Alba: Mild Inflammation and Pigment Loss
Pityriasis alba produces pale, slightly scaly patches most often seen on children’s faces. It’s closely associated with atopic dermatitis (eczema) and is thought to result from a mild, low-grade skin inflammation that disrupts how pigment is produced and distributed.
The patches aren’t caused by a loss of the cells that make pigment. Biopsies show that the number of melanocytes in affected skin is essentially the same as in surrounding normal skin. What changes is how actively those cells work. Affected areas show reduced melanin production, and the tiny pigment packages (melanosomes) inside skin cells are both fewer in number and smaller in size. In more extensive cases, there can be a measurable drop in the number of active melanocytes, which explains why some patches take months to fade even after the underlying inflammation resolves. Sun exposure makes the contrast more noticeable because the surrounding skin tans while the affected patches cannot keep up.
Pityriasis Rubra Pilaris: A Genetic Inflammatory Pathway
Pityriasis rubra pilaris (PRP) is far rarer than the other forms and causes widespread reddish-orange scaling with rough, follicle-based bumps, often covering large areas of the body. Familial cases, where the condition runs in families, have a clearly identified genetic cause: mutations in a gene called CARD14.
CARD14 produces a protein that is expressed in skin at levels five times higher than in any other tissue in the body. This protein activates a signaling pathway called NF-κB, which controls inflammation. In healthy skin, CARD14 activity is mostly confined to the lower layers of the outer skin. In people with PRP-causing mutations, the protein is active all the way up through the upper layers, and the inflammatory signals it triggers are significantly amplified. Biopsies of affected skin show elevated levels of inflammatory markers and a much higher percentage of cells with active inflammatory signaling compared to normal skin. Three distinct mutations in CARD14 have been identified across multiple families, all altering the same structural region of the protein.
Not all PRP is inherited, though. Acquired forms can appear in adults with no family history, and their triggers are less well defined. Some cases have been linked to infections, autoimmune conditions, or malignancy, but for many patients no clear cause is found.
Pityriasis Lichenoides: An Immune Overreaction
Pityriasis lichenoides comes in two forms: a milder chronic version with small scaly bumps that come and go over months, and an acute version (PLEVA) that produces crops of red papules that can blister and leave small scars. Both are uncommon and tend to affect children and young adults.
The exact cause remains unclear, but the leading theory is an exaggerated inflammatory reaction in genetically susceptible people, typically triggered by an infection. Viruses are the most commonly implicated trigger. Two other mechanisms have been proposed: a disordered proliferation of certain immune cells (T-cells), and inflammation driven by immune complexes depositing in small blood vessels. These mechanisms may overlap rather than being mutually exclusive, which could explain why the condition varies so much in severity from person to person.
How These Conditions Are Told Apart
Because many pityriasis types produce round, scaly patches, they can look similar to fungal infections like ringworm, and sometimes to more serious conditions like secondary syphilis. A simple skin scraping tested with a chemical solution can confirm or rule out a fungal cause. Pityriasis rosea is usually diagnosed by its distinctive pattern: the initial large herald patch followed by smaller lesions along skin creases. Pityriasis versicolor patches glow a distinctive color under ultraviolet light. For rarer forms like PRP or pityriasis lichenoides, a skin biopsy is often needed to confirm the diagnosis.
Pityriasis rosea is self-limiting and typically clears within 6 to 12 weeks without treatment. Antiviral medication has been shown to speed resolution of the rash, consistent with the viral reactivation theory. Pityriasis versicolor responds to antifungal treatments but recurs frequently because the yeast remains a permanent resident on the skin. Pityriasis alba generally fades on its own over months to years, especially as children outgrow their eczema tendency. PRP and pityriasis lichenoides are more complex and typically require ongoing management tailored to their severity.